Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_assertion description "[Moreover, agents targeting bone biology (eg, zoledronic acid, anti-DKK-1 MoAb, anti-B-cell activating factor MoAb and bortezomib, Btk inhibitor) show promise not only in preserving bone integrity but also against MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_assertion evidence source_evidence_literature NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_assertion SIO_000772 22215754 NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_assertion wasDerivedFrom befree-20140225 NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_assertion wasGeneratedBy ECO_0000203 NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP749121.RAaUyfXNm5JyILfvsIEhbfAqWqTyEeMM4Ani9xaxTzLKc130_provenance.